• Je něco špatně v tomto záznamu ?

MR enterography with a new negative oral contrast solution containing maghemite nanoparticles

I. Markova, K. Polakova, P. Tucek, M. Mashlan, P. Novak, R. Zboril, M. Herman

. 2012 ; 156 (3) : 229-235.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13039574

AIM: The aim of this study was to test an oral contrast solution with maghemite for the magnetic resonance imaging of small bowel diseases. PATIENTS AND METHODS: The study sample included 3 cohorts: 17 healthy volunteers (group A), 22 patients with small bowel disease (group C). Both groups underwent MR enterography and 24 patients with small bowel disease (group B) underwent magnetic resonance cholecystopancreaticography. Various concentrations in 1000 ml vs 500 ml of experimental solution were tested. All cohorts completed questionnaires evaluating the solution characteristics and side-efects during and after drinking. RESULTS: A maghemite concentration of 800 mg /4 g bentonite in 1000 ml solution was sufficient for proper intraluminal lay-out. An experimental solution of 500 ml was sufficient for magnetic resonance cholecystopancreaticography and 1000 ml for MR enterography. There were no statistically significant differences between groups for taste, taste characteristic or appearance of the experimental solution. Side-effects experienced during drinking were: nausea (29.4%) and eructation (29.4%) in group A, in group B (42%) and diarrhoea (27.3%) in group C. Side-effects 2 h after drinking occured in group A (nausea 17.6%) and in group C (diarrhoea 47%). The best tolerance of experimental solution was found in group B with a higher median patient age than groups A and C. The experimental solution was evaluated more favorably in the older subjects (age over 50 years). CONCLUSION: The experimental oral solution with maghemite was well tolerated in all 3 groups. Our study supports its use in magnetic resonance practice.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13039574
003      
CZ-PrNML
005      
20140109090651.0
007      
ta
008      
131218s2012 xr a f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2012.001 $2 doi
035    __
$a (PubMed)22660214
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Marková, Ingrid $7 xx0106391 $u Department of Radiology, F. D. Roosevelt Faculty Hospital, Banska Bystrica; Department of Radiology, Faculty of Medicine and Dentistry, Palacky University Olomouc
245    10
$a MR enterography with a new negative oral contrast solution containing maghemite nanoparticles / $c I. Markova, K. Polakova, P. Tucek, M. Mashlan, P. Novak, R. Zboril, M. Herman
520    9_
$a AIM: The aim of this study was to test an oral contrast solution with maghemite for the magnetic resonance imaging of small bowel diseases. PATIENTS AND METHODS: The study sample included 3 cohorts: 17 healthy volunteers (group A), 22 patients with small bowel disease (group C). Both groups underwent MR enterography and 24 patients with small bowel disease (group B) underwent magnetic resonance cholecystopancreaticography. Various concentrations in 1000 ml vs 500 ml of experimental solution were tested. All cohorts completed questionnaires evaluating the solution characteristics and side-efects during and after drinking. RESULTS: A maghemite concentration of 800 mg /4 g bentonite in 1000 ml solution was sufficient for proper intraluminal lay-out. An experimental solution of 500 ml was sufficient for magnetic resonance cholecystopancreaticography and 1000 ml for MR enterography. There were no statistically significant differences between groups for taste, taste characteristic or appearance of the experimental solution. Side-effects experienced during drinking were: nausea (29.4%) and eructation (29.4%) in group A, in group B (42%) and diarrhoea (27.3%) in group C. Side-effects 2 h after drinking occured in group A (nausea 17.6%) and in group C (diarrhoea 47%). The best tolerance of experimental solution was found in group B with a higher median patient age than groups A and C. The experimental solution was evaluated more favorably in the older subjects (age over 50 years). CONCLUSION: The experimental oral solution with maghemite was well tolerated in all 3 groups. Our study supports its use in magnetic resonance practice.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a magnetická rezonanční cholangiopankreatografie $7 D049448
650    12
$a kontrastní látky $x škodlivé účinky $7 D003287
650    _2
$a Crohnova nemoc $x diagnóza $7 D003424
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a železité sloučeniny $x škodlivé účinky $x diagnostické užití $7 D005290
650    _2
$a lidé $7 D006801
650    _2
$a tenké střevo $x patologie $7 D007421
650    12
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a nanočástice $7 D053758
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Poláková, Kateřina $u Regional Center of Advanced Technologies and Materials, Department of Physical Chemistry, Faculty of Science, Palacky University Olomouc $7 xx0139779
700    1_
$a Tuček, Pavel $u Department of Geoinformatics, Faculty of Science, Olomouc $7 _AN051497
700    1_
$a Mašláň, Miroslav, $u Center for Nanomaterial Research, Palacky University Olomouc $d 1957- $7 mzk2003202659
700    1_
$a Novák, Pavel $u Medihope s.r.o., Prostejov $7 _AN042119
700    1_
$a Zbořil, Radek, $u Regional Center of Advanced Technologies and Materials, Department of Physical Chemistry, Faculty of Science, Palacky University Olomouc $d 1973- $7 xx0140669
700    1_
$a Heřman, Miroslav, $u Department of Radiology, Faculty of Medicine and Dentistry, Palacky University Olomouc $d 1959- $7 jn20000400945
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 156, č. 3 (2012), s. 229-235
856    41
$u http://biomed.papers.upol.cz/magno/bio/2012/mn3.php $y domovská stránka časopisu - plný text volně přístupný = fulltext
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20131218 $b ABA008
991    __
$a 20140109091352 $b ABA008
999    __
$a ok $b bmc $g 1005872 $s 838075
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 156 $c 3 $d 229-235 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$a Pubmed-20131218
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace